A strong demand has emerged in the life science industry for enabling technologies that can generate, analyze, and interpret genomics and proteomics data much more quickly and cost effectively than currently possible otherwise. Molecular Staging Inc. (MSI), a life sciences company, is addressing this demand with a portfolio of products and services based on technologies that are transforming the detection and measurement of both proteins and nucleic acids. (more...)